IL-15 Enhanced NK Cell Therapy for Solid Tumors
IL-15 Enhanced NK Cell Therapy for Solid Tumors
Recruiting · NCT07621471 · Registry updated 2026-09-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| IL-15 Enhanced NK Cell Therapy for Solid Tumors | Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, metastatic malignant neoplasm, neoplasm | Recruiting | Early phase 1 | 2026-09-30 | NCT07621471 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Genovn Therapeutics (Suzhou) Co., Ltd. | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Xinqiao Hospital | Chongqing | China | 1 |